Related Experiment Videos
Laser treatment in diabetic retinopathy
Transactions of the Ophthalmological Societies of the United Kingdom
|January 1, 1982
Summary
Pan-retinal photocoagulation effectively treated proliferative diabetic retinopathy in most patients, reducing abnormal blood vessels. Some patients required repeat treatments, and common side effects included visual field constriction and reduced night vision.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Research
- Laser Therapy
Background:
- Proliferative diabetic retinopathy (PDR) is a severe complication of diabetes.
- PDR can lead to significant vision loss if left untreated.
Purpose of the Study:
- To evaluate the efficacy and complications of argon laser pan-retinal photocoagulation for PDR.
- To assess the outcomes of laser treatment in a cohort of PDR patients.
Main Methods:
- Retrospective analysis of 44 patients (71 eyes) treated with argon laser pan-retinal photocoagulation.
- Assessment of treatment benefit by observing regression of peripheral and disc vessels.
Main Results:
- Successful treatment outcomes observed in 62 out of 71 eyes (approximately 87%).
- Regression of abnormal retinal vessels was a primary indicator of benefit.
- Complications included visual field constriction, reduced night vision, and macular edema.
Conclusions:
- Argon laser pan-retinal photocoagulation is an effective treatment for proliferative diabetic retinopathy.
- Repeat treatments may be necessary for sustained efficacy.
- Potential complications necessitate careful patient monitoring.